USPTO serial 79363629
FACTORI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 22, 2024
- Examiner
- HARDY LUDLOW, TARAH KIM
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FACTORI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MAURY M. TEPPER, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Machines and manufacturing equipment for cell and gene therapies, namely, machines for manufacturing biopharmaceuticals used for cell culture, cell therapy and gene therapy; components of machines for manufacturing biopharmaceuticals used for cell culture, cell therapy and gene therapy in the nature of racks for holding cell and gene therapy manufacturing equipment; bioreactors for use in manufacturing biopharmaceuticals including cassettes for industrial bioreactors sold as a unit; bioreactors for use in manufacturing biopharmaceuticals including disposable cassettes for industrial bioreactors sold as a unit; parts, including disposable parts for industrial manufacturing equipment for use in manufacturing biopharmaceuticals in cell and gene therapies, namely, sterile connectors for industrial manufacturing apparatus for cell and gene therapy; bellows being containers as parts of machines for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media to or from industrial manufacturing apparatus and equipment; machines and manufacturing equipment for cell and gene therapies, namely, machines for use in manufacturing biopharmaceuticals used for cell culture, cell therapy and gene therapy; industrial bioreactors for use in manufacturing biopharmaceuticals, parts of industrial bioreactors for use in manufacturing biopharmaceuticals, namely, bellows, cassettes, racks and connectors sold as part of a transportable mobile unit or transportable building | ACTIVE | — |
| 009 | Laboratory apparatus and equipment for cell therapy and gene therapy, namely, cell culture hoods, bio-safety cabinets, water baths, cell culture vessels; parts of laboratory apparatus in the nature of bioreactors for gene therapy, namely, bellows, connectors, flexible containers for storing, containing, dispensing or extracting fluids, stem cells, cell cultures or cell culture media sold as part of a transportable mobile unit or transportable building | ACTIVE | — |
| 010 | Medical apparatus and equipment, namely, patient monitors for critical care and anesthesia, anesthesia machines, medical imaging apparatuses, surgical instruments; IV apparatus, namely, intravenous (IV) stands, intravenous (IV) infusion pumps, intravenous (IV) infusion sets; machines in the nature of medical apparatus and instruments for delivering cell and gene therapies to patients, namely, medical syringes, injection sets in the nature of syringes and needles, infusion sets, catheters, cannulas; IV drips in the nature of intravenous bags sold empty for intravenous therapy; cell bags in the nature of intravenous bags sold empty for intravenous cell therapy; bags for collecting blood and fluids from humans or animals for medical purposes; patient side cell therapy and gene therapy machines in the nature of medical apparatus and instruments, namely, incubators, cell culture apparatuses in the nature of cell culture chambers; medical apparatus and instruments for cell and gene therapy, namely, intravenous bags sold empty for intravenous therapy; parts of medical apparatus and instruments for cell and gene therapy, namely, intravenous (IV) stands, intravenous (IV) infusion pumps, intravenous (IV) infusion sets sold as part of a transportable mobile unit or transportable building | ACTIVE | — |
| 019 | pre-fabricated laboratories in the nature of prefabricated non-metal buildings for use as medical laboratories and not for use in manufacturing | ACTIVE | — |
| 037 | Installation, repair, maintenance, and cleaning of bioreactors, scientific and manufacturing equipment | ACTIVE | — |
| 040 | Custom manufacturing of cell therapy and gene therapy products for others, namely, bioreactors, parts of bioreactors, filing machines for bioreactors; custom cell and gene therapy manufacturing for others | ACTIVE | — |
| 042 | Scientific research, design and development services for others in biotechnology; pharmaceutical product design and development of cell therapy products for others; pharmaceutical product development of cell and gene therapy processes for others; technological research consultancy in relation to cell and gene therapy and cell and gene therapy manufacturing processes; rental of scientific laboratory apparatus, equipment and instruments; rental of laboratory apparatus and instruments for cell therapy and gene therapy in the nature of rental of bioreactors and parts, fittings and accessories for bioreactors | ACTIVE | — |
| 044 | Medical services featuring cell and gene therapies delivered to patients; medical treatment services; rental of medical apparatus and instruments for cell and gene therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks owned by Oribiotech Limited
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 019
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named FACTORI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 12, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 25, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 25, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 22, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 22, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 22, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 6, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 6, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 22, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 17, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 27, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jun 27, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 27, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 27, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 27, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 27, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2024 | ALIE | ASSIGNED TO LIE | — |
| Jun 25, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 25, 2024 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jun 25, 2024 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jun 25, 2024 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 16, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 5, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 5, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 5, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 1, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 7, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 7, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 25, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 24, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 14, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 14, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 14, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 14, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 28, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 23, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |